165 related articles for article (PubMed ID: 29077256)
1. Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study.
O'Neill AF; Voss SD; Jagannathan JP; Kamihara J; Nibecker C; Itriago-Araujo E; Masciari S; Parker E; Barreto M; London WB; Garber JE; Diller L
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29077256
[TBL] [Abstract][Full Text] [Related]
2. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
[TBL] [Abstract][Full Text] [Related]
3. Whole-body magnetic resonance imaging of Li-Fraumeni syndrome patients: observations from a two rounds screening of Brazilian patients.
Paixão D; Guimarães MD; de Andrade KC; Nóbrega AF; Chojniak R; Achatz MI
Cancer Imaging; 2018 Aug; 18(1):27. PubMed ID: 30107858
[TBL] [Abstract][Full Text] [Related]
4. Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome.
Kagami LAT; Du YK; Fernandes CJ; Le AN; Good M; Duvall MM; Baldino SE; Powers J; Zelley K; States LJ; Mathew MC; Katona BW; MacFarland SP; Maxwell KN
Cancer Prev Res (Phila); 2023 Sep; 16(9):507-512. PubMed ID: 37428016
[TBL] [Abstract][Full Text] [Related]
5. Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol.
Dixon-Zegeye M; Shaw R; Collins L; Perez-Smith K; Ooms A; Qiao M; Pantziarka P; Izatt L; Tischkowitz M; Harrison RE; George A; Woodward ER; Lord S; Hawkes L; Evans DG; Franklin J; Hanson H; Blagden SP
Trials; 2024 Feb; 25(1):103. PubMed ID: 38308321
[TBL] [Abstract][Full Text] [Related]
6. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Villani A; Shore A; Wasserman JD; Stephens D; Kim RH; Druker H; Gallinger B; Naumer A; Kohlmann W; Novokmet A; Tabori U; Tijerin M; Greer ML; Finlay JL; Schiffman JD; Malkin D
Lancet Oncol; 2016 Sep; 17(9):1295-305. PubMed ID: 27501770
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.
Mai PL; Khincha PP; Loud JT; DeCastro RM; Bremer RC; Peters JA; Liu CY; Bluemke DA; Malayeri AA; Savage SA
JAMA Oncol; 2017 Dec; 3(12):1640-1645. PubMed ID: 28772286
[TBL] [Abstract][Full Text] [Related]
9. Li-Fraumeni Syndrome and Whole-Body MRI Screening: Screening Guidelines, Imaging Features, and Impact on Patient Management.
Consul N; Amini B; Ibarra-Rovira JJ; Blair KJ; Moseley TW; Taher A; Shah KB; Elsayes KM
AJR Am J Roentgenol; 2021 Jan; 216(1):252-263. PubMed ID: 33151095
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic
Bancroft EK; Saya S; Brown E; Thomas S; Taylor N; Rothwell J; Pope J; Chamberlain A; Page E; Benafif S; Hanson H; Dias A; Mikropoulos C; Izatt L; Side L; Walker L; Donaldson A; Cook JA; Barwell J; Wiles V; Limb L; Eccles DM; Leach MO; Shanley S; Gilbert FJ; Gallagher D; Rajashanker B; Whitehouse RW; Koh DM; Sohaib SA; Evans DG; Eeles RA; Walker LG
J Med Genet; 2020 Apr; 57(4):226-236. PubMed ID: 31719169
[TBL] [Abstract][Full Text] [Related]
11. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
[TBL] [Abstract][Full Text] [Related]
12. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
Gozali AE; Britt B; Shane L; Gonzalez I; Gilles F; McComb JG; Krieger MD; Lavey RS; Shlien A; Villablanca JG; Erdreich-Epstein A; Dhall G; Jubran R; Tabori U; Malkin D; Finlay JL
Pediatr Blood Cancer; 2012 Jun; 58(6):905-9. PubMed ID: 21990040
[TBL] [Abstract][Full Text] [Related]
13. Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.
Ballinger ML; Best A; Mai PL; Khincha PP; Loud JT; Peters JA; Achatz MI; Chojniak R; Balieiro da Costa A; Santiago KM; Garber J; O'Neill AF; Eeles RA; Evans DG; Bleiker E; Sonke GS; Ruijs M; Loo C; Schiffman J; Naumer A; Kohlmann W; Strong LC; Bojadzieva J; Malkin D; Rednam SP; Stoffel EM; Koeppe E; Weitzel JN; Slavin TP; Nehoray B; Robson M; Walsh M; Manelli L; Villani A; Thomas DM; Savage SA
JAMA Oncol; 2017 Dec; 3(12):1634-1639. PubMed ID: 28772291
[TBL] [Abstract][Full Text] [Related]
14. [Li-Fraumeni syndrome - a proposal of complex prevention care for carriers of TP53 mutation with total-body MRI].
Foretová L; Stěrba J; Opletal P; Mach V; Lisý J; Petráková K; Palácová M; Navrátilová M; Gaillyová R; Puchmajerová A; Křepelová A; Macháčková E
Klin Onkol; 2012; 25 Suppl():S49-54. PubMed ID: 22920207
[TBL] [Abstract][Full Text] [Related]
15. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update.
Friedman DN; Hsu M; Moskowitz CS; Francis JH; Lis E; Fleischut MH; Oeffinger KC; Walsh M; Tonorezos ES; Sklar CA; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2020 Jul; 67(7):e28389. PubMed ID: 32386119
[TBL] [Abstract][Full Text] [Related]
16. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.
Masciari S; Van den Abbeele AD; Diller LR; Rastarhuyeva I; Yap J; Schneider K; Digianni L; Li FP; Fraumeni JF; Syngal S; Garber JE
JAMA; 2008 Mar; 299(11):1315-9. PubMed ID: 18349092
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of imaging approaches for early tumor detection in children with Li-Fraumeni syndrome.
Tewattanarat N; Junhasavasdikul T; Panwar S; Joshi SD; Abadeh A; Greer MLC; Goldenberg A; Zheng G; Villani A; Malkin D; Doria AS
Pediatr Radiol; 2022 Jun; 52(7):1283-1295. PubMed ID: 35391548
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of Whole-Body MRI as a Tool for Cancer Screening in Children With Genetic Cancer-Predisposing Conditions.
Anupindi SA; Bedoya MA; Lindell RB; Rambhatla SJ; Zelley K; Nichols KE; Chauvin NA
AJR Am J Roentgenol; 2015 Aug; 205(2):400-8. PubMed ID: 26204294
[TBL] [Abstract][Full Text] [Related]
19. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
20. Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study.
Friedman DN; Lis E; Sklar CA; Oeffinger KC; Reppucci M; Fleischut MH; Francis JH; Marr B; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2014 Aug; 61(8):1440-4. PubMed ID: 24402721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]